Premium
A case of uterine tumour resembling ovarian sex cord tumour responding to second‐line, single agent anastrazole
Author(s) -
Blinman P.,
Tattersall M. H. N.
Publication year - 2009
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/j.1445-5994.2009.01998.x
Subject(s) - medicine , aromatase , ovarian cancer , stromal cell , ovary , oncology , hormonal therapy , metastatic breast cancer , cord , breast cancer , gynecology , cancer , surgery
Uterine tumour resembling ovarian sex cord tumour (UTROSCT) are a histological variant of endometrial stromal sarcomas (ESS). There is no established medical management of metastatic UTROSCT or ESS, although there is evidence supporting the use of hormonal therapy. Given the success of aromatase inhibitors in breast cancer, their potential role in ESS and UTROSCT is of current interest. We report the first case of response to second‐line, single agent anastrazole in a patient with metastatic UTROSCT.